Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
The Eastern Democratic Republic of the Congo is suffering a severe setback in its fight against the Mpox outbreak, six weeks after rebels supported by Rwanda took control of two major cities. The DRC ...
6h
Namibian Sun on MSNCongo faces setback in mpox responseAP Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a setback in detecting the disease and offering treatment following the ...
The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...
Brazil has reported its first clade 1b mpox case, per a notice from the national Health Ministry.
2d
The Citizen on MSNTanzania confirms two mpox casesDar es Salaam. The Ministry of Health has confirmed two cases of Mpox, marking the first time the disease has been reported ...
The two confirmed infected individuals have symptoms such as rash, fever, and headache, as well as pain in the body and ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results